Treatment(s) already received-Radical mastectomy Page 2 Posts on Medivizor
Navigation Menu

Treatment(s) already received-Radical mastectomy Posts on Medivizor

The association between insulin blood levels and risk of death in breast cancer patients

Posted by on Feb 28, 2013 in Breast cancer | 0 comments

In a nutshell The present study evaluated the relationship between high insulin levels in the blood stream and the risk of cancer-related mortality. Its authors report that women with higher-than-normal insulin levels are at higher risk of death due to breast cancer. Some background Breast cancer has been shown to be more common in people who...

Read More

Chemotherapy Treatments For Triple-Negative Breast Cancer

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

This paper reviews chemotherapy options for triple-negative breast cancers. Breast cancer cells express 3 main receptors that can be targeted with therapy: Estrogen receptors (ER), Progesterone receptors (PR) and HER2. Triple-negative breast cancers (TNBCs) do not express these 3 receptors and make up approximately 15% of breast cancers. Such tumors do...

Read More

Standard Chemotherapy versus Capecitabine (Xeloda) in Older Women with Early-Stage Breast Cancer

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell This trial compared standard chemotherapy regimens and Capecitabine (Xeloda) in women over 65 years old. The main outcome was that standard chemotherapy worked better in this age group. Some background Capecitabine is generally used in breast cancer resistant to other chemotherapy. It is also the first approved treatment that can be...

Read More

Detecting cancer cells in the blood stream as means to predict recurrence

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell The present study evaluated whether the presence of cancer cells in the blood stream predicts a worse prognosis in women with operable breast cancer. The main finding was that progression-free survival (time before cancer progression) and overall survival were lower if circulating cancer cells were detected in the blood. Some background...

Read More

Does Tamoxifen reduce the risk of cancer in a second breast in BRCA1 and BRCA2 carriers?

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell The risk of breast cancer is high (~80%) in women who inherit a damaged (mutated) gene called BRCA1 or BRCA 2 (‘BRCA carriers’). Following the first diagnosis, their risk of developing another tumor in the second breast within 10 years is 30%. Some background Some types of breast cancer need estrogen (female sex...

Read More